Skip to main content

MICROCHIP TECHNOLOGY INC

For the period ended Sep 30, 2024. Filed Nov 5, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 5, 2024

MCHP$60.33-1.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows –

Six Months Ended September 30,
20242023
Cash flows from operating activities:
Net income$207.7$1,333.0
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization376.3441.9
Deferred income taxes(49.7)27.0
Share-based compensation expense related to equity incentive plans90.389.9
Loss on settlement of debt—12.2
Amortization of debt discount28.14.8
Amortization of debt issuance costs4.34.0
Impairment of intangible assets—1.1
Other(24.3)(0.1)
Changes in operating assets and liabilities, excluding impact of acquisitions:
Decrease (increase) in accounts receivable99.4(400.9)
Increase in inventories(18.3)(5.1)
(Decrease) increase in accounts payable and accrued liabilities(182.3)64.0
Change in other assets and liabilities(50.0)63.9
Change in income tax payable(60.8)(26.3)
Net cash provided by operating activities420.71,609.4
Cash flows from investing activities:
Other investing2.40.4
Proceeds from capital-related government incentives0.1—
Investments in other assets(98.5)(49.6)
Capital expenditures(93.7)(185.5)
Net cash used in investing activities(189.7)(234.7)
Cash flows from financing activities:
Proceeds from borrowings on Revolving Credit Facility—5,551.0
Repayments of Revolving Credit Facility—(5,612.0)
Proceeds from borrowings on 2025 Term Loan Facility—750.0
Proceeds from issuance of Commercial Paper6,354.2995.0
Repayments of Commercial Paper(6,170.6)—
Repayment of senior notes(1,000.0)(2,000.0)
Proceeds from issuance of convertible debt1,250.0—
Payments on settlement of convertible debt—(132.8)
Deferred financing costs(16.5)(1.0)
Purchase of capped call options(105.0)—
Proceeds from sale of common stock33.640.6
Tax payments related to shares withheld for vested RSUs(33.2)(30.4)
Repurchase of common stock(90.0)(480.1)
Payment of cash dividends(486.3)(431.6)
Capital lease payments(0.8)(0.8)
Net cash used in financing activities(264.6)(1,352.1)
Net (decrease) increase in cash and cash equivalents(33.6)22.6
Cash and cash equivalents, and restricted cash at beginning of period319.7234.0
Cash and cash equivalents, and restricted cash at end of period$286.1$256.6
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.